Lung Cancer Considered

By IASLCScience

Lung Cancer Considered episodes

October 31, 2025 LCC in Hungarian: WCLC 2025 Highlights
The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2025 in world languages.
In this episode, host Dr. Zsolt Megyesfalvi moderates a discussion in Hungarian about highlights from the conference with Dr. Zsuzsanna Keleman, Dr. Lilla Horvath, and Dr. Gyula Ostoros.
1 hr 1 min
October 28, 2025 IASLC Lung Cancer Considered: ESMO 2025 Highlights
This episode of Lung Cancer Considered covers highlights from the 2025 ESMO Annual Meeting held October 17th to the 21st in Berlin, Germany.
Guests are:
Dr. Xiuning Le from MD Anderson Cancer Center in Houston, Texas.
Dr. Pedro Rocha from Vall d’Hebron University Hospital in Barcelona, Spain.
Dr. Riyaz Shah, a consultant medical oncologist at the Kent Oncology Centre in the United Kingdom.
38 min
October 21, 2025 Lung Cancer Considered: • Rising Above: The Lung Cancer Hope Summit
In this episode of Lung Cancer Considered, Dr. Narjust Florez leads a discussion with Ann Fish-Steagall and Amanda Nerstad about the 2025 Lung Cancer Hope Summit. The team discusses highlights from the meeting, including groundbreaking research, innovative treatments, and patient advocacy.
47 min
October 10, 2025 LCC in Greek: WCLC 2025 Highlights
The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2025 in world languages.
In this episode, host Dr. Helena Linardou moderates a discussion in Greek about highlights from the conference with Dr. Foteinos-Ioannis Dimitrakopoulos and Dr. Evangelos Sarris.
55 min
October 07, 2025 FDA Approval: Maintenance Lurbinectedin for SCLC
In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses the recent FDA approval of maintenance lurbinectedin plus atezolizumab for extensive stage small cell lung cancer, based on the phase III IMforte trial. Dr. Hossein Borghaei joins the podcast to explain the results and offer perspective on the impact of maintenance therapy for SCLC.
Guest:
Dr. Hossein Borghaei, DO, MS
Chief, Division of Thoracic Medical Oncology
Professor, Department of Hematology/Oncology
Fox Chase Cancer Center
38 min
October 03, 2025 LCC in Arabic: WCLC 2025 Highlights
The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2025 in world languages.
In this episode, host Dr. Nagla Abdel Karim moderates a discussion in Arabic about highlights from the conference with Dr. Riad Abdeljalil, Dr. Khaled Abdel Aziz, Dr. Ashraf Abdel Ghani, Dr. Ahmed Rabea, and Dr. Hussein Soudy.
25 min
October 03, 2025 Lung Cancer Considered in Dutch: Targeting EGFR NSCLC
As part of IASLC’s ongoing series of Lung Cancer Considered podcasts in world languages, Dr. Lizza Hendriks moderates a discussion in Dutch with Dr. Marthe Paats and Dr. Gerrina Ruiter on the treatment of EGFR non-small cell lung cancer.
45 min
October 03, 2025 Lung Cancer Considered: Targeting EGFR NSCLC
Lung Cancer Considered: Targeting EGFR NSCLC by IASLC
45 min
October 02, 2025 Lung Cancer Considered in Japanese---2025 WCLC Highlights
The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2025 in world languages.
In this episode, host Dr. Misako Nagasaka moderates a discussion in Japanese about highlights from the conference with Dr. Hidehito Horinouchi.
Key Topics Covered:
• WCLC 2025 highlights
• FLAURA2
• HARMONi
35 min
September 30, 2025 LCC in Korean: WCLC 2025 Highlights
The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2025 in world languages. In this episode, host Dr. Chul Kim moderates a discussion in Korean about highlights from the conference with Dr. Jeongmin Seo and Dr. Min Hee Hong.
Guest Host:
Chul Kim, MD, MPH
Thoracic Medical Oncologist and Associate Professor
Georgetown University
Instagram: @fe0120
Guest Name(s) & Title(s):
Jeongmin Seo, MD, MSc
Assistant Professor, Medical Oncology
Seoul National University Bundang Hospital
Min Hee Hong, MD
Associate Professor, Yonsei Cancer Center
Severance Hospital, Seoul
21 min

About Lung Cancer Considered

From the publisher's feed

Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 11,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information.